Clinical Trials Directory

Trials / Completed

CompletedNCT01998100

Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exercise + therapy and therapy alone condition) will be compared in terms of levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth of new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptoms PTSD improvement.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProlonged Exposure75-90 minute weekly psychotherapy sessions x 12 weeks, focused on gradually confronting distressing trauma-related memories and reminders.
BEHAVIORALExercise30 minutes of moderate-intensity treadmill exercise prior to the Prolonged Exposure

Timeline

Start date
2010-09-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2013-11-28
Last updated
2015-12-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01998100. Inclusion in this directory is not an endorsement.